Sihuan Pharmaceutical Holdings Group Ltd SHPHY의 지난 분기 매출 실적은 어땠나요?
Sihuan Pharmaceutical Holdings Group Ltd의 매출 추정치는 얼마인가요?
Sihuan Pharmaceutical Holdings Group Ltd의 수익 품질 점수는 얼마인가요?
Sihuan Pharmaceutical Holdings Group Ltd는 언제 수익을 보고하나요?
Sihuan Pharmaceutical Holdings Group Ltd의 예상 수익은 얼마인가요?
Sihuan Pharmaceutical Holdings Group Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
SIHUAN PHARMACEUTICAL HOLD GP L란 무엇인가요?
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 2,767 full-time employees. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.